Organic compounds

Global Vinyl Chloride Monomer (VCM) Industry Outlook to 2024 - Capacity and Capital Expenditure Forecasts with Details of All Active and Planned Plants

Tuesday, December 1, 2020 - 6:40pm

Global Vinyl Chloride Monomer (VCM) capacity is expected to experience considerable growth over the next five years from 49.38 mtpa in 2019 to 54.81 mtpa by 2024.

Key Points: 
  • Global Vinyl Chloride Monomer (VCM) capacity is expected to experience considerable growth over the next five years from 49.38 mtpa in 2019 to 54.81 mtpa by 2024.
  • Around 14 planned and announced VCM plants are expected to come online, primarily in Asia and North America over the next five years.
  • Shin-Etsu Chemical Co Ltd, Tianjin Bohai Chemical Industry Co Ltd and China Shenhua Energy Co Ltd are the top three companies in terms of planned and announced capacity additions during the outlook period.
  • Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

Polyvinyl Alcohol (PVA) Films Market - Global Growth, Trends, and Forecast to 2025 - ResearchAndMarkets.com

Tuesday, December 1, 2020 - 5:49pm

The "Polyvinyl Alcohol (PVA) Films Market - Growth, Trends, and Forecast (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Polyvinyl Alcohol (PVA) Films Market - Growth, Trends, and Forecast (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering.
  • The polyvinyl alcohol film market is expected to grow during the forecast period, owing to the increasing demand for unit-dose packaging.
  • Polyvinyl alcohol films are widely used in single-use packaging applications, and they are expected to be the fastest-growing market during the forecast period.
  • The polyvinyl alcohol films market is partially fragmented, with players accounting for a marginal share of the market.

Global Ultra-High Molecular Weight Polyethylene Market Trends, Forecast, and Opportunity Analysis Report 2021 - ResearchAndMarkets.com

Tuesday, December 1, 2020 - 4:25pm

Du Pont De Nemours and Company, Honeywell International Inc., Toyobo Co. Limited, and Rochling Engineering Plastics SE & Co. KG

Key Points: 
  • Du Pont De Nemours and Company, Honeywell International Inc., Toyobo Co. Limited, and Rochling Engineering Plastics SE & Co. KG
    Some of the features of 'Global Ultra-High Molecular Weight Polyethylene Market 2019-2024: Trends, Forecast, and Opportunity Analysis' include
    Market size estimates: Global Ultra-high molecular weight polyethylene market size estimation in terms of value ($M) shipment.
  • Segmentation analysis: Global market size by various applications such as by form, end use industry, and region
    Regional analysis: Global Ultra-high molecular weight polyethylene market breakdown by North America, Europe, Asia Pacific, and the Rest of the World
    Growth opportunities: Analysis on growth opportunities in different applications and regions for Ultra-high molecular weight polyethylene in the global Ultra-high molecular weight polyethylene market.
  • Strategic analysis: This includes M&A, new product development, and competitive landscape for ultra-high molecular weight polyethylene in the global ultra-high molecular weight polyethylene market.
  • Market Trends and Forecast Analysis from 2013 to 2024:
    3.2: Global Ultra-High Molecular Weight Polyethylene Market: Trends and Forecast
    3.3: Global Ultra-High Molecular Weight Polyethylene Market By Form:

Rhizen Pharmaceuticals Announces US FDA Acceptance of its IND Application for RP7214 in SARS-CoV-2 Infection; Phase 1 Clinical Trial of RP7214 Set to Begin Early December 2020

Tuesday, December 1, 2020 - 3:01pm

The company announced that initial study shall evaluate single ascending doses of RP7214 in healthy volunteers and that dosing is expected to commence in early December 2020.

Key Points: 
  • The company announced that initial study shall evaluate single ascending doses of RP7214 in healthy volunteers and that dosing is expected to commence in early December 2020.
  • The company also announces positive feedback from the FDA during its pre-IND discussion on its plans to follow-up this study with a multiple-ascending dose study in Covid-19 patients.
  • RP7214 is potentially a best-in-class selective DHODH inhibitor that has shown potent inhibition of Covid-19 viral replication.
  • We are pleased to advance RP7214 into a Phase 1 clinical trial for the treatment of Covid-19 under a US FDA IND.

Elevar Therapeutics and Tanner Pharma Group Announce Launch of Global Named Patient Program to Provide Access to Apealea® (paclitaxel micellar)

Tuesday, December 1, 2020 - 2:00pm

Apealea received market authorization by the European Commission in November 2018, making it Europe's first non-Cremophor EL formulation of paclitaxel approved for use in ovarian cancer.

Key Points: 
  • Apealea received market authorization by the European Commission in November 2018, making it Europe's first non-Cremophor EL formulation of paclitaxel approved for use in ovarian cancer.
  • Elevar Therapeutics has offices in Utah, California and South Korea, and additional information is available at www.elevartherapeutics.com .
  • Tanner Pharma Group is a specialist pharmaceutical services provider based in Charlotte, USA with offices in Europe and Latin America.
  • Over 18 years, Tanner has developed a portfolio of service offerings focused on improving the global access to medicines.

Automotive and Electronics High Value-grab Opportunities for Polyphthalamide Market, Valuation to Reach ~ US$ 2.5 BN by 2027

Tuesday, December 1, 2020 - 1:30pm

Of the various end-use industries, automotive held the leading share in 2018

Key Points: 
  • Of the various end-use industries, automotive held the leading share in 2018
    Globally the polyphthalamides market was pegged at ~ US$ 1.3 Bn in 2018.
  • Growing utilization of PPA in high-temperature and moisture-resistant applications in the electrical and electronics industry has bolstered the prospects of the polyphthalamide market.
  • The growth is propelled by the proliferating use of PPA and its composites in the electronics and automotive industry.
  • Some of the key players in the polyphthalamide market are SABIC, RTP Company, Inc., Solvay S.A., Evonik Industries AG, and EMS-GRIVORY.

Automotive and Electronics High Value-grab Opportunities for Polyphthalamide Market, Valuation to Reach ~ US$ 2.5 BN by 2027

Tuesday, December 1, 2020 - 1:30pm

Of the various end-use industries, automotive held the leading share in 2018

Key Points: 
  • Of the various end-use industries, automotive held the leading share in 2018
    Globally the polyphthalamides market was pegged at ~ US$ 1.3 Bn in 2018.
  • Growing utilization of PPA in high-temperature and moisture-resistant applications in the electrical and electronics industry has bolstered the prospects of the polyphthalamide market.
  • The growth is propelled by the proliferating use of PPA and its composites in the electronics and automotive industry.
  • Some of the key players in the polyphthalamide market are SABIC, RTP Company, Inc., Solvay S.A., Evonik Industries AG, and EMS-GRIVORY.

One Million Children Receive Essential Vitamin A Through Persona™ Nutrition and Vitamin Angels®

Tuesday, December 1, 2020 - 1:00pm

We will continue to be a reliable partner to help Vitamin Angels advance its mission and help more children grow and develop."

Key Points: 
  • We will continue to be a reliable partner to help Vitamin Angels advance its mission and help more children grow and develop."
  • Vitamin A is a group of essential fat-soluble compounds that is essential for the process of vision, cell growth and development and immune function.
  • "We are proud Persona Nutrition has been a partner of Vitamin Angels for the past three years, and has helped us reach one million children who need vitamin A the most.
  • With every Persona vitamin pack order, two children who are at risk of malnutrition receive essential vitamin A.

COVID-19 Impact and Recovery Analysis | Styrene Copolymers Procurement Intelligence Report Forecasts over USD $ 6 billion Spend Growth | SpendEdge

Tuesday, December 1, 2020 - 5:30am

The global styrene copolymers is poised to experience spend growth of more than USD $ 6 billion between 2024 at a CAGR of over 3.50%.

Key Points: 
  • The global styrene copolymers is poised to experience spend growth of more than USD $ 6 billion between 2024 at a CAGR of over 3.50%.
  • Our styrene copolymers procurement intelligence report offers actionable procurement intelligence insights, sourcing strategies, and action plans to mitigate risks arising out of the current pandemic situation.
  • While this will increase suppliers OPEX, this will have an inflationary impact on buyers styrene copolymers procurement expenditure.
  • This styrene copolymers procurement intelligence report has enlisted the top suppliers and their cost structures, SLA terms, best selection criteria, and negotiation strategies.

First Experiments in Space for COVID-19 Drug Research With Kirara

Tuesday, December 1, 2020 - 1:00am

Remdesivir, to be applicable for its intravenous infusion, requires formulation by the excipient cyclodextrin called SBECD.

Key Points: 
  • Remdesivir, to be applicable for its intravenous infusion, requires formulation by the excipient cyclodextrin called SBECD.
  • Although it is considered today as one of the most promising drugs for COVID-19 treatment, remarkable efficacy of remdesivir-SBECD complex has not yet been confirmed.
  • Kirara is a high-quality protein crystal growth service provided by JAMSS for drug discovery support.
  • It could be applied to the field of materials such as cellulose as well as drug discovery support.